OHE OHE
Close
OHE
Newsletter SignupSubscribe

Drug development Process and R&D

New medicines lead to improved patient outcomes and societal benefits, but R&D is a long and costly process. Ongoing health economics research aims to find the right balance between incentivising manufacturers to innovate and ensuring affordable access for health systems.

Filter results by

Theme
Select the product option you would like to filter Theme
Tag
Select the product option you would like to filter Tag
Date 1
Select the product option you would like to filter Date
Date From
Date To
Author
Select the product option you would like to filter Author
Content type
Select the product option you would like to filter Content type
Slide3
  • Blog
  • October 2022

The Economics of Antibiotics – Part 3: Creating a Healthy Global Market for New Antibiotics

Read more
On a dollar bill are pills of a medicine capsule.
  • Blog
  • June 2022

Estimating the Impact of U.S. Drug Price-setting Policies on Innovation Is Challenging, Even for the Congressional Budget Office

Read more
Adult and child hands holding lung, world tuberculosis day, worl
  • Blog
  • March 2022

Invest to End TB. Save Lives. World TB Day 2022. Reflections on 60 years of OHE publications on TB.

Read more
  • Blog
  • February 2022

How Does Pharmaceutical Spending Drive Innovation in Europe?

Read more
Annual Lecture 2021
  • Past Event
  • Annual lecture
  • September 2021

Virtual OHE Annual Lecture 2021: Do Patents Work? Evidence from Pharmaceutical Innovation

Read more
  • Blog
  • July 2021

How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?

Read more
Fig1-2
  • Blog
  • June 2021

Towards a New Understanding of Unmet Medical Need

Read more
  • Blog
  • May 2021

Would Waiving COVID-19 Vaccines Patents Save Lives?

Read more
  • Blog
  • March 2021

Does Government Funding Increase Public Sector Development of New Medicines?

Read more
  • News
  • June 2020

OHE Authors Develop a Supply and Demand Model of Pharmaceutical Markets to Set Cost-Effectiveness Thresholds to Maximise and Distribute Social Welfare

Read more
Load More